David serves as the Head of Operations and Impact at Adjuvant Capital where he leads fund and impact operations including ESG integration and impact due diligence, measurement and management. He joined Adjuvant from Bridgespan, where he was a Manager on Bridgespan’s Impact Investing Management Team. As a member of this team, David helped lead Bridgespan’s efforts to partner with impact investors to develop their own impact due diligence systems, publish related insights, and speak about best practices. Outside of his impact investing projects, David worked with a diverse set of public health actors—including direct service organizations and funders such as The End Fund, Planned Parenthood, Last Mile Health, and the Robert Wood Johnson Foundation—to develop operating models, strategic plans, learning and innovation processes, and investment proposals.
Prior to joining Bridgespan, David worked as a Guyer Fellow at Save the Children (child health), a program analyst at the Ford Foundation (financial inclusion), and an investment analyst in McKinsey & Co.’s investment office (MIO Partners). David earned his MBA/MPH with honors (Tuck Scholar) from Dartmouth College where he was a Wilson Scholar and his BA cum laude with departmental distinctions from Yale University.